Following the deadline for the submission of abstracts to the 2021 meeting, we have now made a tentative program for the meeting. All presenters will be contacted within the next few days and asked to confirm their presentation.
The meeting will take place as a virtual meeting from 12.30-16.00 CET on April 21st and 22nd. Registration to the meeting will open mid february, and more information on this will be provided at that time.
The tentative program overview:
Wednesday April 21st 12.30-16.00
12.30-13.40: Session I: Welcome and situation updates
14.15-15.00: Session II: Experience from the field
15.15-16.00: Session III: CMS –host interaction and diagnostic potential
Thursday April 22nd 12.30-16.00
12.30-13.30: Session IV: Molecular epidemiology
13:45-14:10: Intermission:Information from TriNation and our sponsors
14.10-15.15: Session V: Vaccine development
15.15-16.00: Session VI: Vaccine evaluation